Nuclera has announced a $12million extension to its Series C round which raised $75m in October 2024. The raise was led by ...

Following the installation of eProtein Discovery at leading academic institutes across the UK and Europe 1, the expansion ...

Creating analytical tools that support the advancement of knowledge can often come about through the integration of existing information and techniques, theoretical and practical, directed toward a ...

Protein yield and ease of purification are two important criteria in choosing a system for the expression/ purification of recombinant proteins. The IMPACT (Intein Mediated Purification with an ...

CAMBRIDGE, England--(BUSINESS WIRE)--Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, and Domainex, a multi-award ...

Protein samples are essential to advance our understanding of disease pathways and develop new therapeutics. High-quality filtration is needed to protect purity, yield and functionality of target ...

There are a wide variety of protein-based drugs that are used to treat various serious conditions. Insulin is perhaps the most well-known example, which is used for life-saving treatments for diabetes ...

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research ...